JAMA Article Raises Question Of Bias In Industry-Funded Studies
This article was originally published in The Gray Sheet
Executive SummaryCompany-sponsored cardiovascular device studies tend to report positive results for investigational therapies more often than trials funded by nonprofits, according to research published in the May 17 issue of the Journal of the American Medical Association
You may also be interested in...
The European Court of Justice has confirmed the European Medicines Agency’s approach to disclosure of data submitted as part of a marketing authorization application. It is a big disappointment for industry, which nonetheless says it supports responsible data sharing and will support efforts to develop a balanced approach.
Dr Reddy’s sees its Indian domestic market and China as hot prospects as it pursues its “transformation journey” in which it is reducing its dependence on the slowing US market.